AAM
ALNY icon

Azzad Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Azzad Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Hold
4,591
– – 0.15% 178
2025
Q4 		$1.83M Sell
4,591
-29
-0.6% -$12.8K 0.18% 175
2025
Q3 		$2.11M Buy
4,620
+1,969
+74% +$802K 0.21% 167
2025
Q2 		$864K Buy
+2,651
New +$734K 0.09% 240
2023
Q3 		– Sell
-2,725
Closed -$518K – 303
2023
Q2 		$518K Buy
2,725
+11
+0.4% +$2.18K 0.07% 271
2023
Q1 		$544K Buy
2,714
+19
+0.7% +$3.99K 0.08% 265
2022
Q4 		$641K Buy
2,695
+24
+0.9% +$5.12K 0.1% 237
2022
Q3 		$535K Buy
2,671
+5
+0.2% +$954 0.05% 336
2022
Q2 		$389K Buy
2,666
+62
+2% +$8.8K 0.04% 354
2022
Q1 		$425K Sell
2,604
-83
-3% -$12.6K 0.06% 280
2021
Q4 		$456K Buy
+2,687
New +$499K 0.06% 295

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return